CATUG Biotechnology provides novel CRDMO services with a particular focus on mRNA vaccines and therapeutics, as well as gene and cell therapy (GCT). Plasmid, mRNA, LNP, and analytical QC are their four fundamental technology platforms. CATUG aims to provide end-to-end solutions to its clients in the life cycle of mRNA therapeutics and GCT product development. The company customizes unique services and creative solutions to fit each client's needs and timeline.
